{
    "code": "52026662",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026662",
    "time": "2021-02-12 03:44:43",
    "許可證字號": "衛部藥輸字第026662號",
    "註銷狀態": "已註銷",
    "註銷日期": "110\/01\/26",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "110\/01\/07",
    "發證日期": "105\/01\/07",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202666209",
    "中文品名": "坦克干膜衣錠60毫克",
    "英文品名": "Daklinza Tablet 60mg",
    "適應症": "適應症：1.與sofosbuvir併用，治療成人慢性C型肝炎基因型第1、2、3型之感染。2.與asunaprevir併用，治療代償性肝病(包括肝硬化)成人慢性C型肝炎基因型第1b型之感染。3.與asunaprevir、peginterferon及ribavirin併用，治療代償性肝病(包括肝硬化)成人慢性C型肝炎基因型第1型之感染。4.與peginterferon及ribavirin併用，治療成人慢性C型肝炎基因型第4型之感染。",
    "劑型": "116膜衣錠",
    "包裝": "2~1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "110\/01\/07",
    "主成分略述": "Daclatasvir Dihydrochloride",
    "限制項目": "02輸　入 1D須執行風險管理計畫 1Q不得輸入 51免除銜接性臨床試驗",
    "申請商名稱": "1404501100  臺灣必治妥施貴寶股份有限公司",
    "申請商地址": "台北市松山區健康路156號4樓、5樓",
    "主製造廠": [
        {
            "製造廠名稱": "FUS0373000  AstraZeneca Pharmaceuticals LP",
            "製造廠廠址": "4601 HIGHWAY 62 EAST, MOUNT VERNON, INDIANA 47620 USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FIT0287100  BRISTOL-MYERS SQUIBB S.R.L.",
            "製造廠廠址": "LOCALIT&#39;A FONTANA DEL CERASO 03012 ANAGNI ITALY",
            "製造廠公司地址": "",
            "製造廠國別": "ITALY",
            "製程": "分包裝廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818005100",
            "成分名稱": "Daclatasvir Dihydrochloride",
            "含量描述": "(eq to Daclatasvir 60mg)",
            "含量": "66.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "衛部藥輸字第026662號 坦克干膜衣錠60毫克 藥品外觀-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026662&Seq=003&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Daklinza 中文仿單_AUPI 31Oct2016=CCDS 26Aug2016[B] rev-107-04-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026662&Seq=004&Type=9"
        },
        {
            "title": "Daklinza 60毫克外盒-107-04-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026662&Seq=004&Type=8"
        }
    ]
}